-
1
-
-
30944455145
-
Insulin resistance: A metabolic pathway to chronic liver disease
-
Excellent review on insulin resistance and liver injury
-
Bugianesi E, McCullough AJ, Marchesini G: Insulin resistance: a metabolic pathway to chronic liver disease. Hepatology 42, 987-1000 (2005). ■ Excellent review on insulin resistance and liver injury.
-
(2005)
Hepatology
, vol.42
, pp. 987-1000
-
-
Bugianesi, E.1
McCullough, A.J.2
Marchesini, G.3
-
2
-
-
0033200054
-
Nonalcoholic steatohepatitis: A proposal for grading and staging the histological lesions
-
Classic description of histological lesions in nonalcoholic fatty liver disease (NAFLD) and a widely accepted proposal for grading/staging
-
Brunt EM, Janney CG, DiBisceglie AM et al.: Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am. J. Gastroenterol. 94, 2467-2474 (1999). ■ Classic description of histological lesions in nonalcoholic fatty liver disease (NAFLD) and a widely accepted proposal for grading/staging.
-
(1999)
Am. J. Gastroenterol.
, vol.94
, pp. 2467-2474
-
-
Brunt, E.M.1
Janney, C.G.2
Dibisceglie, A.M.3
-
3
-
-
33750312195
-
Non-invasive markers associated with liver fibrosis in non-alcoholic fatty liver disease
-
DOI 10.1136/gut.2006.091454
-
Guha IN, Parkes J, Roderick PR et al.: Non-invasive markers associated with liver fibrosis in non-alcoholic fatty liver disease. Gut 55, 1650-1660 (2006). (Pubitemid 44629217)
-
(2006)
Gut
, vol.55
, Issue.11
, pp. 1650-1660
-
-
Guha, I.N.1
Parkes, J.2
Roderick, P.R.3
Harris, S.4
Rosenberg, W.M.5
-
4
-
-
0037382786
-
Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome
-
DOI 10.1053/jhep.2003.50161
-
Marchesini G, Bugianesi E, Forlani G et al.: Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 37, 917-923 (2003). (Pubitemid 36397405)
-
(2003)
Hepatology
, vol.37
, Issue.4
, pp. 917-923
-
-
Marchesini, G.1
Bugianesi, E.2
Forlani, G.3
Cerrelli, F.4
Lenzi, M.5
Manini, R.6
Natale, S.7
Vanni, E.8
Villanova, N.9
Melchionda, N.10
Rizzetto, M.11
-
5
-
-
0028875908
-
The natural history of nonalcoholic fatty liver: A follow-up study
-
Teli MR, James OFW, Burt D et al.: The natural history of nonalcoholic fatty liver: a follow-up study. Hepatology 22, 1714-1719 (1995).
-
(1995)
Hepatology
, vol.22
, pp. 1714-1719
-
-
Teli, M.R.1
James, O.F.W.2
Burt, D.3
-
7
-
-
22344452893
-
The natural history of nonalcoholic fatty liver disease: A population-based cohort study
-
One of the first studies to demonstrate increased mortality and, specifically, liver-related mortality in nonalcoholic steatohepatitis (NASH) patients
-
Adams LA, Lymp JF, St Sauver J et al.: The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 129, 113-121 (2005). ■ One of the first studies to demonstrate increased mortality and, specifically, liver-related mortality in nonalcoholic steatohepatitis (NASH) patients.
-
(2005)
Gastroenterology
, vol.129
, pp. 113-121
-
-
Adams, L.A.1
Lymp, J.F.2
St Sauver, J.3
-
8
-
-
0033038672
-
Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity
-
DOI 10.1016/S0016-5085(99)70506-8
-
Matteoni CA, Younossi ZM, Gramlich T et al.: Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 116, 1413-1419 (1999). (Pubitemid 29258890)
-
(1999)
Gastroenterology
, vol.116
, Issue.6
, pp. 1413-1419
-
-
Matteoni, C.A.1
Younossi, Z.M.2
Gramlich, T.3
Boparai, N.4
Yao Chang, L.5
McCullough, A.J.6
-
9
-
-
20444443042
-
Sampling variability of liver biopsy in nonalcoholic fatty liver disease
-
Ratziu V, Charlotte F, Heurtier A et al.: Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology 128, 1898-1906 (2005).
-
(2005)
Gastroenterology
, vol.128
, pp. 1898-1906
-
-
Ratziu, V.1
Charlotte, F.2
Heurtier, A.3
-
10
-
-
2342419920
-
Long term prognosis of fatty liver: Risk of chronic liver disease and death
-
DOI 10.1136/gut.2003.019984
-
Dam-Larsen S, Franzmann M, Andersen IB et al.: Long term prognosis of fatty liver: risk of chronic liver disease and death. Gut 53, 750-755 (2004). (Pubitemid 38561456)
-
(2004)
Gut
, vol.53
, Issue.5
, pp. 750-755
-
-
Dam-Larsen, S.1
Franzmann, M.2
Andersen, I.B.3
Christoffersen, P.4
Jensen, L.B.5
Sorensen, T.I.A.6
Becker, U.7
Bendtsen, F.8
-
11
-
-
0344099066
-
Prognosis of Patients with a Diagnosis of Fatty Liver - A Registry-based Cohort Study
-
Jepsen P, Vilstrup H, Mellemkjaer L et al.: Prognosis of patients with a diagnosis of fatty liver - a registry-based cohort study. Hepatogastroenterology 50, 2101-2104 (2003). (Pubitemid 37468003)
-
(2003)
Hepato-Gastroenterology
, vol.50
, Issue.54
, pp. 2101-2104
-
-
Jepsen, P.1
Vilstrup, H.2
Mellemkjaer, L.3
Thulstrup, A.M.4
Olsen, J.H.5
Baron, J.A.6
Sorensen, H.T.7
-
12
-
-
33750606061
-
Long-term follow-up of patients with NAFLD and elevated liver enzymes
-
Important study confirming increased overall, liver-related and cardiovascular mortality
-
Ekstedt M, Franzen LE, Mathiesen UL et al.: Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology 44, 865-873 (2006). ■ Important study confirming increased overall, liver-related and cardiovascular mortality.
-
(2006)
Hepatology
, vol.44
, pp. 865-873
-
-
Ekstedt, M.1
Franzen, L.E.2
Mathiesen, U.L.3
-
13
-
-
20044374023
-
Design and validation of a histological scoring system for nonalcoholic fatty liver disease
-
DOI 10.1002/hep.20701
-
Kleiner DE, Brunt EM, Van Natta M et al.: Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41, 1313-1321 (2005). ■ Important attempt to devise a histological scoring system for clinical trials. (Pubitemid 40770284)
-
(2005)
Hepatology
, vol.41
, Issue.6
, pp. 1313-1321
-
-
Kleiner, D.E.1
Brunt, E.M.2
Van Natta, M.3
Behling, C.4
Contos, M.J.5
Cummings, O.W.6
Ferrell, L.D.7
Liu, Y.-C.8
Torbenson, M.S.9
Unalp-Arida, A.10
Yeh, M.11
McCullough, A.J.12
Sanyal, A.J.13
-
14
-
-
0031844760
-
Nonalcoholic fatty liver disease: Assessment of variability in pathologic interpretations
-
Younossi ZM, Gramlich T, Liu YC et al.: Non-alcoholic fatty liver disease: assessment of variability in pathologic interpretations. Mod. Pathol. 11, 560-565 (1998). (Pubitemid 28280720)
-
(1998)
Modern Pathology
, vol.11
, Issue.6
, pp. 560-565
-
-
Younossi, Z.M.1
Gramlich, T.2
Yao, C.L.3
Matteoni, C.4
Petrelli, M.5
Goldblum, J.6
Rybicki, L.7
McCullough, A.J.8
-
15
-
-
0034950652
-
Nonalcoholic fatty liver disease: Predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese
-
Dixon JB, Bhathal PS, O'Brien PE: Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology 121, 91-100 (2001).
-
(2001)
Gastroenterology
, vol.121
, pp. 91-100
-
-
Dixon, J.B.1
Bhathal, P.S.2
O'Brien, P.E.3
-
16
-
-
46249084411
-
A clinical scoring system for predicting nonalcoholic steatohepatitis in morbidly obese patients
-
Campos GM, Bambha K, Vittinghoff E et al.: A clinical scoring system for predicting nonalcoholic steatohepatitis in morbidly obese patients. Hepatology 47, 1916-1923 (2008).
-
(2008)
Hepatology
, vol.47
, pp. 1916-1923
-
-
Campos, G.M.1
Bambha, K.2
Vittinghoff, E.3
-
17
-
-
16244368502
-
Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients
-
DOI 10.1381/0960892053576820
-
Ong JP, Elariny H, Collantes R et al.: Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients. Obes. Surg. 15, 310-315 (2005). (Pubitemid 40463594)
-
(2005)
Obesity Surgery
, vol.15
, Issue.3
, pp. 310-315
-
-
Ong, J.P.1
Elariny, H.2
Collantes, R.3
Younoszai, A.4
Chandhoke, V.5
Reines, H.D.6
Goodman, Z.7
Younossi, Z.M.8
-
18
-
-
0242443339
-
Prevalence and Predictors of Asymptomatic Liver Disease in Patients Undergoing Gastric Bypass Surgery
-
DOI 10.1001/archsurg.138.11.1240
-
Beymer C, Kowdley KV, Larson A et al.: Prevalence and predictors of asymptomatic liver disease in patients undergoing gastric bypass surgery. Arch. Surg. 138, 1240-1244 (2003). (Pubitemid 37392401)
-
(2003)
Archives of Surgery
, vol.138
, Issue.11
, pp. 1240-1244
-
-
Beymer, C.1
Kowdley, K.V.2
Larson, A.3
Edmonson, P.4
Dellinger, E.P.5
Flum, D.R.6
-
19
-
-
33645090537
-
Race and comorbid factors predict nonalcoholic fatty liver disease histopathology in severely obese patients
-
Solga SF, Clark JM, Alkhuraishi AR et al.: Race and comorbid factors predict nonalcoholic fatty liver disease histopathology in severely obese patients. Surg. Obes. Relat. Dis. 1, 6-11 (2005).
-
(2005)
Surg. Obes. Relat. Dis.
, vol.1
, pp. 6-11
-
-
Solga, S.F.1
Clark, J.M.2
Alkhuraishi, A.R.3
-
20
-
-
25844500757
-
Predictors of nonalcoholic steatohepatitis (NASH) in obese patients undergoing gastric bypass
-
DOI 10.1381/0960892055002347
-
Boza C, Riquelme A, Ibanez L et al.: Predictors of nonalcoholic steatohepatitis (NASH) in obese patients undergoing gastric bypass. Obes. Surg. 15, 1148-1153 (2005). (Pubitemid 41390213)
-
(2005)
Obesity Surgery
, vol.15
, Issue.8
, pp. 1148-1153
-
-
Boza, C.1
Riquelme, A.2
Ibanez, L.3
Duarte, I.4
Norero, E.5
Viviani, P.6
Soza, A.7
Fernandez, J.I.8
Raddatz, A.9
Guzman, S.10
Arrese, M.11
-
21
-
-
33644535823
-
Prevalence and predictive factors of non-alcoholic steatohepatitis (NASH) in morbidly obese patients undergoing bariatric surgery
-
DOI 10.1381/096089206775565122
-
Harnois F, Msika S, Sabate JM et al.: Prevalence and predictive factors of non-alcoholic steatohepatitis (NASH) in morbidly obese patients undergoing bariatric surgery. Obes. Surg. 16, 183-188 (2006). (Pubitemid 43302243)
-
(2006)
Obesity Surgery
, vol.16
, Issue.2
, pp. 183-188
-
-
Harnois, F.1
Msika, S.2
Sabate, J.-M.3
Mechler, C.4
Jouet, P.5
Barge, J.6
Coffin, B.7
-
22
-
-
29744468433
-
Abnormal glucose tolerance is a predictor of steatohepatitis and fibrosis in patients with non-alcoholic fatty liver disease
-
DOI 10.1080/00365520500264953
-
Haukeland JW, Konopski Z, Linnestad P et al.: Abnormal glucose tolerance is a predictor of steatohepatitis and fibrosis in patients with non-alcoholic fatty liver disease. Scand. J. Gastroenterol. 40, 1469-1477 (2005). (Pubitemid 43028210)
-
(2005)
Scandinavian Journal of Gastroenterology
, vol.40
, Issue.12
, pp. 1469-1477
-
-
Haukeland, J.W.1
Konopski, Z.2
Linnestad, P.3
Azimy, S.4
Loberg, E.M.5
Haaland, T.6
Birkeland, K.7
Bjoro, K.8
-
23
-
-
3042744737
-
Beyond insulin resistance in NASH: TNF-α or adiponectin?
-
DOI 10.1002/hep.20280
-
Hui JM, Hodge A, Farrell GC et al.: Beyond insulin resistance in NASH: TNF-α or adiponectin? Hepatology 40, 46-54 (2004). (Pubitemid 38868922)
-
(2004)
Hepatology
, vol.40
, Issue.1
, pp. 46-54
-
-
Hui, J.M.1
Hodge, A.2
Farrell, G.C.3
Kench, J.G.4
Kriketos, A.5
George, J.6
-
24
-
-
30944469306
-
Adipokines in NASH: Postprandial lipid metabolism as a link between adiponectin and liver disease
-
DOI 10.1002/hep.20896
-
Musso G, Gambino R, Durazzo M et al.: Adipokines in NASH: postprandial lipid metabolism as a link between adiponectin and liver disease. Hepatology 42, 1175-1183 (2005). (Pubitemid 43112685)
-
(2005)
Hepatology
, vol.42
, Issue.5
, pp. 1175-1183
-
-
Musso, G.1
Gambino, R.2
Durazzo, M.3
Biroli, G.4
Carello, M.5
Faga, E.6
Pacini, G.7
De Michieli, F.8
Rabbione, L.9
Premoli, A.10
Cassader, M.11
Pagano, G.12
-
25
-
-
33646853899
-
Associations between plasma adiponectin concentrations and liver histology in patients with nonalcoholic fatty liver disease
-
DOI 10.1111/j.1365-2265.2006.02527.x
-
Targher G, Bertolini L, Rodella S et al.: Associations between plasma adiponectin concentrations and liver histology in patients with nonalcoholic fatty liver disease. Clin. Endocrinol. (Oxf.) 64, 679-683 (2006). (Pubitemid 43775007)
-
(2006)
Clinical Endocrinology
, vol.64
, Issue.6
, pp. 679-683
-
-
Targher, G.1
Bertolini, L.2
Rodella, S.3
Zoppini, G.4
Scala, L.5
Zenari, L.6
Falezza, G.7
-
26
-
-
21244445862
-
Plasma Adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity
-
DOI 10.1210/jc.2004-2240
-
Bugianesi E, Pagotto U, Manini R et al.: Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity. J. Clin. Endocrinol. Metab. 90, 3498-3504 (2005). (Pubitemid 41014319)
-
(2005)
Journal of Clinical Endocrinology and Metabolism
, vol.90
, Issue.6
, pp. 3498-3504
-
-
Bugianesi, E.1
Pagotto, U.2
Manini, R.3
Vanni, E.4
Gastaldelli, A.5
De Iasio, R.6
Gentilcore, E.7
Natale, S.8
Cassader, M.9
Rizzetto, M.10
Pasquali, R.11
Marchesini, G.12
-
27
-
-
33646013904
-
Clinical model for distinguishing nonalcoholic steatohepatitis from simple steatosis in patients with nonalcoholic fatty liver disease
-
Palekar NA, Naus R, Larson SP et al.: Clinical model for distinguishing nonalcoholic steatohepatitis from simple steatosis in patients with nonalcoholic fatty liver disease. Liver Int. 26, 151-156 (2006).
-
(2006)
Liver Int.
, vol.26
, pp. 151-156
-
-
Palekar, N.A.1
Naus, R.2
Larson, S.P.3
-
28
-
-
0041302377
-
The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice
-
DOI 10.1172/JCI200317797
-
Xu A, Wang Y, Keshaw H et al.: The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice. J. Clin. Invest. 112, 91-100 (2003). ■ Experimental data in favor of a protective role for adiponectin in NAFLD. (Pubitemid 38056380)
-
(2003)
Journal of Clinical Investigation
, vol.112
, Issue.1
, pp. 91-100
-
-
Xu, A.1
Wang, Y.2
Keshaw, H.3
Xu, L.Y.4
Lam, K.S.L.5
Cooper, G.J.S.6
-
29
-
-
34548532367
-
Serum adipokine levels predictive of liver injury in patients with non-alcoholic fatty liver disease
-
Lemoine M, Ratziu V, Maachi M et al.: Serum adipokine levels predictive of liver injury in patients with non-alcoholic fatty liver disease. J. Hepatol. 42, 24A (2005).
-
(2005)
J. Hepatol.
, vol.42
-
-
Lemoine, M.1
Ratziu, V.2
Maachi, M.3
-
30
-
-
33748184089
-
Metabolic and adipokine profile of Chinese patients with nonalcoholic fatty liver disease
-
Wong VW, Hui AY, Tsang SW et al.: Metabolic and adipokine profile of Chinese patients with nonalcoholic fatty liver disease. Clin. Gastroenterol. Hepatol. 4, 1154-1161 (2006).
-
(2006)
Clin. Gastroenterol. Hepatol.
, vol.4
, pp. 1154-1161
-
-
Wong, V.W.1
Hui, A.Y.2
Tsang, S.W.3
-
31
-
-
4143146390
-
Liver damage in severely obese patients: A clinical-biochemical- morphologic study on 1,000 liver biopsies
-
DOI 10.1381/0960892041719644
-
Papadia FS, Marinari GM, Camerini G et al.: Liver damage in severely obese patients: a clinical-biochemical-morphologic study on 1,000 liver biopsies. Obes. Surg. 14, 952-958 (2004). (Pubitemid 39093470)
-
(2004)
Obesity Surgery
, vol.14
, Issue.7
, pp. 952-958
-
-
Papadia, F.S.1
Marinari, G.M.2
Camerini, G.3
Murelli, F.4
Carlini, F.5
Stabilini, C.6
Scopinaro, N.7
-
32
-
-
19944433151
-
Clinical usefulness of biochemical markers of liver fibrosis in patients with nonalcoholic fatty liver disease
-
Sakugawa H, Nakayoshi T, Kobashigawa K et al.: Clinical usefulness of biochemical markers of liver fibrosis in patients with nonalcoholic fatty liver disease. World J. Gastroenterol. 11, 255-259 (2005). (Pubitemid 40125214)
-
(2005)
World Journal of Gastroenterology
, vol.11
, Issue.2
, pp. 255-259
-
-
Sakugawa, H.1
Nakayoshi, T.2
Kobashigawa, K.3
Yamashiro, T.4
Maeshiro, T.5
Miyagi, S.6
Shiroma, J.7
Toyama, A.8
Nakayoshi, T.9
Kinjo, F.10
Saito, A.11
-
33
-
-
33747090739
-
Liver breath tests non-invasively predict higher stages of non-alcoholic steatohepatitis
-
DOI 10.1042/CS20050346
-
Portincasa P, Grattagliano I, Lauterburg BH et al.: Liver breath tests non-invasively predict higher stages of non-alcoholic steatohepatitis. Clin. Sci. 111, 135-143 (2006). (Pubitemid 44220527)
-
(2006)
Clinical Science
, vol.111
, Issue.2
, pp. 135-143
-
-
Portincasa, P.1
Grattagliano, I.2
Lauterburg, B.H.3
Palmieri, V.O.4
Palasciano, G.5
Stellaard, F.6
-
34
-
-
33646831000
-
Breath biomarkers and non-alcoholic fatty liver disease: Preliminary observations
-
DOI 10.1080/13547500500421070, PII P3754472040474
-
Solga SF, Alkhuraishe A, Cope K et al.: Breath biomarkers and non-alcoholic fatty liver disease: preliminary observations. Biomarkers 11, 174-183 (2006). (Pubitemid 43772014)
-
(2006)
Biomarkers
, vol.11
, Issue.2
, pp. 174-183
-
-
Solga, S.F.1
Alkhuraishe, A.2
Cope, K.3
Tabesh, A.4
Clark, J.M.5
Torbenson, M.6
Schwartz, P.7
Magnuson, T.8
Diehl, A.M.9
Risby, T.H.10
-
35
-
-
34547596738
-
High-sensitivity C-reactive protein is an independent clinical feature of nonalcoholic steatohepatitis (NASH) and also of the severity of fibrosis in NASH
-
DOI 10.1007/s00535-007-2060-x
-
Yoneda M, Mawatari H, Fujita K et al.: High-sensitivity C-reactive protein is an independent clinical feature of nonalcoholic steatohepatitis (NASH) and also of the severity of fibrosis in NASH. J. Gastroenterol. 42, 573-582 (2007). (Pubitemid 47190075)
-
(2007)
Journal of Gastroenterology
, vol.42
, Issue.7
, pp. 573-582
-
-
Yoneda, M.1
Mawatari, H.2
Fujita, K.3
Iida, H.4
Yonemitsu, K.5
Kato, S.6
Takahashi, H.7
Kirikoshi, H.8
Inamori, M.9
Nozaki, Y.10
Abe, Y.11
Kubota, K.12
Saito, S.13
Iwasaki, T.14
Terauchi, Y.15
Togo, S.16
Maeyama, S.17
Nakajima, A.18
-
36
-
-
33746703237
-
The inflammatory C-reactive protein is increased in both liver and adipose tissue in severely obese patients independently from metabolic syndrome, Type 2 diabetes, and NASH
-
Anty R, Bekri S, Luciani N et al.: The inflammatory C-reactive protein is increased in both liver and adipose tissue in severely obese patients independently from metabolic syndrome, Type 2 diabetes, and NASH. Am. J. Gastroenterol. 101, 1824-1833 (2006).
-
(2006)
Am. J. Gastroenterol.
, vol.101
, pp. 1824-1833
-
-
Anty, R.1
Bekri, S.2
Luciani, N.3
-
37
-
-
0036780582
-
Pathogenesis of steatohepatitis
-
Interesting review on the pathophysiology of NASH
-
Day CP: Pathogenesis of steatohepatitis. Best Pract. Res. Clin. Gastroenterol. 16, 663-678 (2002). ■ Interesting review on the pathophysiology of NASH.
-
(2002)
Best Pract. Res. Clin. Gastroenterol.
, vol.16
, pp. 663-678
-
-
Day, C.P.1
-
38
-
-
4444382031
-
Systemic levels of lipid peroxidation and its metabolic and dietary correlates in patients with nonalcoholic steatohepatitis
-
DOI 10.1111/j.1572-0241.2004.30159.x
-
Chalasani N, Deeg MA, Crabb DW: Systemic levels of lipid peroxidation and its metabolic and dietary correlates in patients with nonalcoholic steatohepatitis. Am. J. Gastroenterol. 99, 1497-1502 (2004). (Pubitemid 39193189)
-
(2004)
American Journal of Gastroenterology
, vol.99
, Issue.8
, pp. 1497-1502
-
-
Chalasani, N.1
Deeg, M.A.2
Crabb, D.W.3
-
39
-
-
33644918908
-
Blood oxidative stress markers are unreliable markers of hepatic steatosis
-
DOI 10.1111/j.1365-2036.2006.02719.x
-
Bonnefont-Rousselot D, Ratziu V, Giral P et al.: Blood oxidative stress markers are unreliable markers of hepatic steatosis. Aliment. Pharmacol. Ther. 23, 91-98 (2006). (Pubitemid 43381171)
-
(2006)
Alimentary Pharmacology and Therapeutics
, vol.23
, Issue.1
, pp. 91-98
-
-
Bonnefont-Rousselot, D.1
Ratziu, V.2
Giral, P.3
Charlotte, F.4
Beucler, I.5
Poynard, T.6
-
40
-
-
20244370723
-
Systemic markers of lipid peroxidation and antioxidants in patients with nonalcoholic fatty liver disease
-
DOI 10.1111/j.1572-0241.2005.41500.x
-
Yesilova Z, Yaman H, Oktenli C et al.: Systemic markers of lipid peroxidation and antioxidants in patients with nonalcoholic fatty liver disease. Am. J. Gastroenterol. 100, 850-855 (2005). (Pubitemid 40592378)
-
(2005)
American Journal of Gastroenterology
, vol.100
, Issue.4
, pp. 850-855
-
-
Yesilova, Z.1
Yaman, H.2
Oktenli, C.3
Ozcan, A.4
Uygun, A.5
Cakir, E.6
Sanisoglu, S.Y.7
Erdil, A.8
Ates, Y.9
Aslan, M.10
Musabak, U.11
Erbil, M.K.12
Karaeren, N.13
Dagalp, K.14
-
41
-
-
37549069361
-
Blood oxidative stress markers in nonalcoholic steatohepatitis and how it correlates with diet
-
Machado MV, Ravasco P, Jesus L et al.: Blood oxidative stress markers in nonalcoholic steatohepatitis and how it correlates with diet. Scand. J. Gastroenterol. 43, 95-102 (2008).
-
(2008)
Scand. J. Gastroenterol.
, vol.43
, pp. 95-102
-
-
Machado, M.V.1
Ravasco, P.2
Jesus, L.3
-
42
-
-
58249104011
-
Plasma pentraxin 3 is a novel marker for nonalcoholic steatohepatitis (NASH)
-
Yoneda M, Uchiyama T, Kato S et al.: Plasma pentraxin 3 is a novel marker for nonalcoholic steatohepatitis (NASH). BMC Gastroenterol. 8, 53 (2008).
-
(2008)
BMC Gastroenterol.
, vol.8
, pp. 53
-
-
Yoneda, M.1
Uchiyama, T.2
Kato, S.3
-
43
-
-
0037232972
-
Serum thioredoxin levels as a predictor of steatohepatitis in patients with nonalcoholic fatty liver disease
-
DOI 10.1016/S0168-8278(02)00331-8, PII S0168827802003318
-
Sumida Y, Nakashima T, Yoh T et al.: Serum thioredoxin levels as a predictor of steatohepatitis in patients with nonalcoholic fatty liver disease. J. Hepatol. 38, 32-38 (2003). (Pubitemid 36078521)
-
(2003)
Journal of Hepatology
, vol.38
, Issue.1
, pp. 32-38
-
-
Sumida, Y.1
Nakashima, T.2
Yoh, T.3
Furutani, M.4
Hirohama, A.5
Kakisaka, Y.6
Nakajima, Y.7
Ishikawa, H.8
Mitsuyoshi, H.9
Okanoue, T.10
Kashima, K.11
Nakamura, H.12
Yodoi, J.13
-
44
-
-
34547539428
-
Usefulness of a combined evaluation of the serum adiponectin level, HOMA-IR, and serum type IV collagen 7S level to predict the early stage of nonalcoholic steatohepatitis
-
Shimada M, Kawahara H, Ozaki K et al.: Usefulness of a combined evaluation of the serum adiponectin level, HOMA-IR, and serum type IV collagen 7S level to predict the early stage of nonalcoholic steatohepatitis. Am. J. Gastroenterol. 102, 1931-1938 (2007).
-
(2007)
Am. J. Gastroenterol.
, vol.102
, pp. 1931-1938
-
-
Shimada, M.1
Kawahara, H.2
Ozaki, K.3
-
45
-
-
67349263467
-
Decreased plasma levels of soluble receptor for advanced glycation endproducts (sRAGE) in patients with nonalcoholic fatty liver disease
-
Yilmaz Y, Ulukaya E, Gul OO et al.: Decreased plasma levels of soluble receptor for advanced glycation endproducts (sRAGE) in patients with nonalcoholic fatty liver disease. Clin. Biochem. 42, 802-807 (2009).
-
(2009)
Clin. Biochem.
, vol.42
, pp. 802-807
-
-
Yilmaz, Y.1
Ulukaya, E.2
Gul, O.O.3
-
46
-
-
12344267742
-
Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV FibroSure) and necrosis (ActiTest) in patients with chronic hepatitis C
-
DOI 10.1186/1476-5926-3-8
-
Poynard T, Imbert-Bismut F, Munteanu M et al.: Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV FibroSure) and necrosis (ActiTest) in patients with chronic hepatitis C. Comp. Hepatol. 3, 8 (2004). (Pubitemid 40230475)
-
(2004)
Comparative Hepatology
, vol.3
, pp. 8
-
-
Poynard, T.1
Imbert-Bismut, F.2
Munteanu, M.3
Messous, D.4
Myers, R.P.5
Thabut, D.6
Rtziu, V.7
Mercadier, A.8
Benhamou, Y.9
Hainque, B.10
-
47
-
-
3242798959
-
Prospective analysis of discordant results between biochemical markers and biopsy in patients with chronic hepatitis C
-
Important aspect of a validation of any noninvasive method
-
Poynard T, Munteanu M, Imbert-Bismut F et al.: Prospective analysis of discordant results between biochemical markers and biopsy in patients with chronic hepatitis C. Clin. Chem. 50, 1344-1355 (2004). ■ Important aspect of a validation of any noninvasive method.
-
(2004)
Clin. Chem.
, vol.50
, pp. 1344-1355
-
-
Poynard, T.1
Munteanu, M.2
Imbert-Bismut, F.3
-
48
-
-
9644279531
-
Serum markers detect the presence of liver fibrosis: A cohort study
-
A promising marker of fibrosis in NASH
-
Rosenberg WM, Voelker M, Thiel R et al.: Serum markers detect the presence of liver fibrosis: a cohort study. Gastroenterology 127, 1704-1713 (2004). ■ A promising marker of fibrosis in NASH.
-
(2004)
Gastroenterology
, vol.127
, pp. 1704-1713
-
-
Rosenberg, W.M.1
Voelker, M.2
Thiel, R.3
-
49
-
-
32144449983
-
A novel panel of blood markers to assess the degree of liver fibrosis
-
DOI 10.1002/hep.20935
-
Cales P, Oberti F, Michalak S et al.: A novel panel of blood markers to assess the degree of liver fibrosis. Hepatology 42, 1373-1381 (2005). (Pubitemid 43260040)
-
(2005)
Hepatology
, vol.42
, Issue.6
, pp. 1373-1381
-
-
Cales, P.1
Oberti, F.2
Michalak, S.3
Hubert-Fouchard, I.4
Rousselet, M.-C.5
Konate, A.6
Gallois, Y.7
Ternisien, C.8
Chevallier, A.9
Lunel, F.10
-
50
-
-
33845207096
-
Diagnostic value of biochemical markers (NashTest) for the prediction of non alcoholo steato hepatitis in patients with non-alcoholic fatty liver disease
-
One of the few biomarkers designed and validated specifically for NASH
-
Poynard T, Ratziu V, Charlotte F et al.: Diagnostic value of biochemical markers (NashTest) for the prediction of non alcoholo steato hepatitis in patients with non-alcoholic fatty liver disease. BMC Gastroenterol. 6, 34 (2006). ■ One of the few biomarkers designed and validated specifically for NASH.
-
(2006)
BMC Gastroenterol.
, vol.6
, pp. 34
-
-
Poynard, T.1
Ratziu, V.2
Charlotte, F.3
-
51
-
-
33748250671
-
Diagnostic and predictive factors of significant liver fibrosis and minimal lesions in patients with persistent unexplained elevated transaminases. A prospective multicenter study
-
A national, multicentric collaboration demonstrating that steatosis and steatohepatitis each account for a quarter of patients with unexplained alanine aminotransferase elevations
-
de Ledinghen V, Ratziu V, Causse X et al.: Diagnostic and predictive factors of significant liver fibrosis and minimal lesions in patients with persistent unexplained elevated transaminases. A prospective multicenter study. J. Hepatol. 45, 592-599 (2006). ■ A national, multicentric collaboration demonstrating that steatosis and steatohepatitis each account for a quarter of patients with unexplained alanine aminotransferase elevations.
-
(2006)
J. Hepatol.
, vol.45
, pp. 592-599
-
-
De Ledinghen, V.1
Ratziu, V.2
Causse, X.3
-
53
-
-
0042165989
-
Hepatocyte apoptosis and Fas expression are prominent features of human nonalcoholic steatohepatitis
-
DOI 10.1016/S0016-5085(03)00907-7
-
Feldstein AE, Canbay A, Angulo P et al.: Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis. Gastroenterology 125, 437-443 (2003). ■ One of the first studies to demonstrate apoptosis in NASH. (Pubitemid 36929425)
-
(2003)
Gastroenterology
, vol.125
, Issue.2
, pp. 437-443
-
-
Feldstein, A.E.1
Canbay, A.2
Angulo, P.3
Taniai, M.4
Burgart, L.J.5
Lindor, K.D.6
Gores, G.J.7
-
54
-
-
33745904468
-
In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease
-
A promising biomarker for NASH awaiting further validation
-
Wieckowska A, Zein NN, Yerian LM et al.: In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease. Hepatology 44, 27-33 (2006). ■ A promising biomarker for NASH awaiting further validation.
-
(2006)
Hepatology
, vol.44
, pp. 27-33
-
-
Wieckowska, A.1
Zein, N.N.2
Yerian, L.M.3
-
55
-
-
37749032395
-
Noninvasive diagnosis of nonalcoholic fatty liver disease using serum biomarkers
-
author reply 2048
-
Mitry RR, De Bruyne R, Quaglia A et al.: Noninvasive diagnosis of nonalcoholic fatty liver disease using serum biomarkers. Hepatology 46, 2047-2048; author reply 2048 (2007).
-
(2007)
Hepatology
, vol.46
, pp. 2047-2048
-
-
Mitry, R.R.1
De Bruyne, R.2
Quaglia, A.3
-
56
-
-
33947528311
-
Soluble forms of extracellular cytokeratin 18 may differentiate simple steatosis from nonalcoholic steatohepatitis
-
Yilmaz Y, Dolar E, Ulukaya E et al.: Soluble forms of extracellular cytokeratin 18 may differentiate simple steatosis from nonalcoholic steatohepatitis. World J. Gastroenterol. 13, 837-844 (2007). (Pubitemid 46470292)
-
(2007)
World Journal of Gastroenterology
, vol.13
, Issue.6
, pp. 837-844
-
-
Yilmaz, Y.1
Dolar, E.2
Ulukaya, E.3
Akgoz, S.4
Keskin, M.5
Kiyici, M.6
Aker, S.7
Yilmaztepe, A.8
Gurel, S.9
Gulten, M.10
Nak, S.G.11
-
57
-
-
55149102644
-
Cytokeratin 18 fragment levels as a noninvasive biomarker for nonalcoholic steatohepatitis in bariatric surgery patients
-
Diab DL, Yerian L, Schauer P et al.: Cytokeratin 18 fragment levels as a noninvasive biomarker for nonalcoholic steatohepatitis in bariatric surgery patients. Clin. Gastroenterol. Hepatol. 6, 1249-1254 (2008).
-
(2008)
Clin. Gastroenterol. Hepatol.
, vol.6
, pp. 1249-1254
-
-
Diab, D.L.1
Yerian, L.2
Schauer, P.3
-
58
-
-
53849114643
-
A novel diagnostic biomarker panel for obesity-related nonalcoholic steatohepatitis (NASH)
-
Younossi ZM, Jarrar M, Nugent C et al.: A novel diagnostic biomarker panel for obesity-related nonalcoholic steatohepatitis (NASH). Obes. Surg. 18, 1430-1437 (2008).
-
(2008)
Obes. Surg.
, vol.18
, pp. 1430-1437
-
-
Younossi, Z.M.1
Jarrar, M.2
Nugent, C.3
-
59
-
-
33845592323
-
Serum concentrations of the tissue polypeptide specific antigen in patients suffering from non-alcoholic steatohepatitis
-
DOI 10.1111/j.1365-2362.2007.01745.x
-
Tarantino G, Conca P, Coppola A et al.: Serum concentrations of the tissue polypeptide specific antigen in patients suffering from non-alcoholic steatohepatitis. Eur. J. Clin. Invest. 37, 48-53 (2007). (Pubitemid 44934772)
-
(2007)
European Journal of Clinical Investigation
, vol.37
, Issue.1
, pp. 48-53
-
-
Tarantino, G.1
Conca, P.2
Coppola, A.3
Vecchione, R.4
Di Minno, G.5
-
60
-
-
25644448266
-
Fat in the liver and insulin resistance
-
Yki-Jarvinen H: Fat in the liver and insulin resistance. Ann. Med. 37, 347-356 (2005).
-
(2005)
Ann. Med.
, vol.37
, pp. 347-356
-
-
Yki-Jarvinen, H.1
-
61
-
-
33751545838
-
A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis
-
DOI 10.1056/NEJMoa060326
-
Belfort R, Harrison SA, Brown K et al.: A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis. N. Engl. J. Med. 355, 2297-2307 (2006). (Pubitemid 44837778)
-
(2006)
New England Journal of Medicine
, vol.355
, Issue.22
, pp. 2297-2307
-
-
Belfort, R.1
Harrison, S.A.2
Brown, K.3
Darland, C.4
Finch, J.5
Hardies, J.6
Balas, B.7
Gastaldelli, A.8
Tio, F.9
Pulcini, J.10
Berria, R.11
Ma, J.Z.12
Dwivedi, S.13
Havranek, R.14
Fincke, C.15
Defronzo, R.16
Bannayan, G.A.17
Schenker, S.18
Cusi, K.19
-
62
-
-
46349088361
-
Rosiglitazone for Nonalcoholic Steatohepatitis: One-Year Results of the Randomized Placebo-Controlled Fatty Liver Improvement with Rosiglitazone Therapy (FLIRT) Trial
-
DOI 10.1053/j.gastro.2008.03.078, PII S0016508508006306
-
Ratziu V, Giral P, Jacqueminet S et al.: Rosiglitazone for nonalcoholic steatohepatitis: one-year results of the randomized placebo-controlled Fatty Liver Improvement with Rosiglitazone Therapy (FLIRT) trial. Gastroenterology 135, 100-110 (2008). (Pubitemid 351916703)
-
(2008)
Gastroenterology
, vol.135
, Issue.1
, pp. 100-110
-
-
Ratziu, V.1
Giral, P.2
Jacqueminet, S.3
Charlotte, F.4
Hartemann-Heurtier, A.5
Serfaty, L.6
Podevin, P.7
Lacorte, J.8
Bernhardt, C.9
Bruckert, E.10
Grimaldi, A.11
Poynard, T.12
-
63
-
-
53049101877
-
Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis
-
Aithal GP, Thomas JA, Kaye PV et al.: Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis. Gastroenterology 135, 1176-1184 (2008).
-
(2008)
Gastroenterology
, vol.135
, pp. 1176-1184
-
-
Aithal, G.P.1
Thomas, J.A.2
Kaye, P.V.3
-
64
-
-
66649083733
-
Serum proteomic profiling of obese patients: Correlation with liver pathology and evolution after bariatric surgery
-
Trak-Smayra V, Dargere D, Noun R et al.: Serum proteomic profiling of obese patients: correlation with liver pathology and evolution after bariatric surgery. Gut 58, 825-832 (2009).
-
(2009)
Gut
, vol.58
, pp. 825-832
-
-
Trak-Smayra, V.1
Dargere, D.2
Noun, R.3
-
65
-
-
34548309212
-
Diagnostic value of serum protein profiling by SELDI-TOF ProteinChip compared with a biochemical marker, FibroTest, for the diagnosis of advanced fibrosis in patients with chronic hepatitis C
-
DOI 10.1111/j.1365-2036.2007.03427.x
-
Morra R, Munteanu M, Bedossa P et al.: Diagnostic value of serum protein profiling by SELDI-TOF ProteinChip compared with a biochemical marker, FibroTest, for the diagnosis of advanced fibrosis in patients with chronic hepatitis C. Aliment. Pharmacol. Ther. 26, 847-858 (2007). (Pubitemid 47346704)
-
(2007)
Alimentary Pharmacology and Therapeutics
, vol.26
, Issue.6
, pp. 847-858
-
-
Morra, R.1
Munteanu, M.2
Bedossa, P.3
Dargere, D.4
Janneau, J.-L.5
Paradis, V.6
Ratziu, V.7
Charlotte, F.8
Thibault, V.9
Imbert-Bismut, F.10
Poynard, T.11
|